SUBSCRIPTION AGREEMENT (NON-BROKERED)Subscription Agreement • November 15th, 2017 • Trillium Therapeutics Inc. • Pharmaceutical preparations • New York
The undersigned (the “Subscriber”) hereby irrevocably subscribes for, and the Company hereby irrevocably accepts the subscription by the Subscriber for, the number of common shares (“Common Shares”) and/or Series 2 non-voting convertible first preferred shares (“Preferred Shares”) of the Company (collectively, the “Shares”) for the aggregate subscription price set forth below, representing a subscription price of US$8.50 per Common Share and US$8.50 per Preferred Share, upon and subject to the terms and conditions set forth in this Subscription Agreement, including the “Terms of Offering” attached hereto. In addition to this face page, the Subscriber must also complete all applicable schedules attached hereto.
